Your browser doesn't support javascript.
loading
Advances in Animal Models and Cutting-Edge Research in Alternatives: Proceedings of the Third International Conference on 3Rs Research and Progress, Vishakhapatnam, 2022.
Naik, Nikita Narayan; Vadloori, Bharadwaja; Poosala, Suresh; Srivastava, Pratima; Coecke, Sandra; Smith, Adrian; Akhtar, Aysha; Roper, Clive; Radhakrishnan, Sridhar; Bhyravbhatla, Balaji; Damle, Madhujit; Pulla, Venkat Koushik; Hackethal, Johannes; Horland, Reyk; Li, Albert P; Pati, Falguni; Singh, Manu Smriti; Occhetta, Paola; Bisht, Rohit; Dandekar, Prajakta; Bhagavatula, Krishna; Pajkrt, Dasja; Johnson, Michael; Weber, Tilo; Huang, John; Hysenaj, Lisiena; Mallar, Banerjee; Ramray, Bhat; Dixit, Santosh; Joshi, Shreekanth; Kulkarni, Mandar.
Affiliation
  • Naik NN; Oncoseek Bio Pvt Ltd, Hyderabad, India.
  • Vadloori B; Oncoseek Bio Pvt Ltd, Hyderabad, India.
  • Poosala S; Oncoseek Bio Pvt Ltd, Hyderabad, India.
  • Srivastava P; Biology Discovery and Services Division, Aragen Life Science, Hyderabad, India.
  • Coecke S; European Commission Joint Research Centre, Ispra, Italy.
  • Smith A; Norecopa c/o Norwegian Veterinary Institute, Oslo, Norway.
  • Akhtar A; Center for Contemporary Sciences, Gaithersburg, MD, USA.
  • Roper C; Roper Toxicology Consulting Limited, Edinburgh, UK.
  • Radhakrishnan S; Research Diets Inc, New Brunswick, NJ, USA.
  • Bhyravbhatla B; HyLasCo Bio-Technology (India) Pvt Ltd, Hyderabad, India.
  • Damle M; Molecular Devices, Mumbai, India.
  • Pulla VK; Merck Life Sciences, Mumbai, India.
  • Hackethal J; THT Biomaterials GmbH, Vienna, Austria.
  • Horland R; TissUse GmbH, Berlin, Germany.
  • Li AP; Discovery Life Sciences, Columbia, MD, USA.
  • Pati F; Department of Biomedical Engineering, IIT Hyderabad, Hyderabad, India.
  • Singh MS; Department of Biotechnology and Center of Excellence for Nanosensors and Nanomedicines, Bennett University, Noida, India.
  • Occhetta P; BiomimX Srl, Milan, Italy.
  • Bisht R; Department of Science-Regulatory Toxicology, People for the Ethical Treatment of Animals (PETA), Delhi, India.
  • Dandekar P; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, India.
  • Bhagavatula K; The Jackson Laboratory, Bar Harbor, ME, USA.
  • Pajkrt D; Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Johnson M; Visikol, Hampton, NJ, USA.
  • Weber T; Animal Welfare Academy of the German Animal Welfare Federation, Neubiberg, Germany.
  • Huang J; TheWell Bioscience, North Brunswick, NJ, USA.
  • Hysenaj L; Parvus Therapeutics Inc., South San Francisco, CA, USA.
  • Mallar B; Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India.
  • Ramray B; BioSystems Science and Engineering, Indian Institute of Science, Bangalore, India.
  • Dixit S; Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India.
  • Joshi S; BioSystems Science and Engineering, Indian Institute of Science, Bangalore, India.
  • Kulkarni M; Persistent Systems, Pune, India.
Altern Lab Anim ; 51(4): 263-288, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37282515
ABSTRACT
Animal experimentation has been integral to drug discovery and development and safety assessment for many years, since it provides insights into the mechanisms of drug efficacy and toxicity (e.g. pharmacology, pharmacokinetics and pharmacodynamics). However, due to species differences in physiology, metabolism and sensitivity to drugs, the animal models can often fail to replicate the effects of drugs and chemicals in human patients, workers and consumers. Researchers across the globe are increasingly applying the Three Rs principles by employing innovative methods in research and testing. The Three Rs concept focuses on the replacement of animal models (e.g. with in vitro and in silico models or human studies), on the reduction of the number of animals required to achieve research objectives, and on the refinement of existing experimental practices (e.g. eliminating distress and enhancing animal wellbeing). For the last two years, Oncoseek Bio-Acasta Health, a 3-D cell culture-based cutting-edge translational biotechnology company, has organised an annual International Conference on 3Rs Research and Progress. This series of global conferences aims to bring together researchers with diverse expertise and interests, and provides a platform where they can share and discuss their research to promote practices according to the Three Rs principles. In November 2022, the 3rd international conference, Advances in Animal Models and Cutting-Edge Research in Alternatives, took place at the GITAM University in Vishakhapatnam (AP, India) in a hybrid format (i.e. online and in-person). These conference proceedings provide details of the presentations, which were categorised under five different topic sessions. It also describes a special interactive session on in silico strategies for preclinical research in oncology, which was held at the end of the first day.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Animal Experimentation Limits: Animals / Humans Country/Region as subject: Asia Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Animal Experimentation Limits: Animals / Humans Country/Region as subject: Asia Language: En Year: 2023 Type: Article